Narcolepsy Latest Advances
Find the Latest Research About Narcolepsy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5717 publications
Briefing Chat: New narcolepsy drug could unlock host of novel brain therapies.
Journal: Nature
Published: August 21, 2026
Oveporexton: The first-in-class orexin receptor 2 (OX2R) agonist approved for treatment of narcolepsy type 1 (NT1).
Journal: Drug discoveries & therapeutics
Published: August 19, 2026
Daily briefing: Narcolepsy drug could kick off an Ozempic-style moment for the brain.
Journal: Nature
Published: August 19, 2026
First-of-its-kind narcolepsy drug opens door to new therapies for the brain.
Journal: Nature
Published: August 18, 2026
Orexin receptor agonist secures landmark narcolepsy approval.
Journal: Nature reviews. Drug discovery
Published: August 10, 2026
Correction to: Narcolepsy and risk of cardiovascular outcomes beyond stimulant use.
Journal: Sleep
Published: August 09, 2026
Global and Partial Cataplexy, Geste Antagoniste, and Startle Response in Narcolepsy Type 1.
Journal: JAMA neurology
Published: August 03, 2026
Development of Narcolepsy Type 1 Following COVID-19 Infection in a Patient Previously Diagnosed With Idiopathic Hypersomnia: A Case Report.
Journal: Cureus
Published: July 19, 2026
Oxytocin in the amygdala links social and reward signals to cataplexy in mice.
Journal: Nature neuroscience
Published: July 14, 2026
Last Updated: 09/26/2026